EP Patent

EP2719382A1 — Ethyl Eicosapentanoate and Pharmaceutical Compositions Comprising Ethyl Eicosapentanoate as an Active Ingredient for Use in the Treatment of Non-Alcoholic Steatohepatitis

Assigned to Mochida Pharmaceutical Co Ltd · Expires 2014-04-16 · 12y expired

What this patent protects

Ethyl eicosapentanoate and compositions comprising this compound as an active ingredient for use in the treatment or alleviation of symptoms of non-alcoholic steatohepatitis (NASH) are disclosed.

USPTO Abstract

Ethyl eicosapentanoate and compositions comprising this compound as an active ingredient for use in the treatment or alleviation of symptoms of non-alcoholic steatohepatitis (NASH) are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2719382A1
Jurisdiction
EP
Classification
—
Expires
2014-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Mochida Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.